Abbott Laboratories Future Growth

Future criteria checks 2/6

Abbott Laboratories is forecast to grow earnings and revenue by 11.8% and 6.5% per annum respectively. EPS is expected to grow by 11.9% per annum. Return on equity is forecast to be 21.5% in 3 years.

Key information

11.8%

Earnings growth rate

11.9%

EPS growth rate

Medical Equipment earnings growth16.9%
Revenue growth rate6.5%
Future return on equity21.5%
Analyst coverage

Good

Last updated19 Jul 2024

Recent future growth updates

The Abbott Laboratories (NYSE:ABT) Full-Year Results Are Out And Analysts Have Published New Forecasts

Jan 26
The Abbott Laboratories (NYSE:ABT) Full-Year Results Are Out And Analysts Have Published New Forecasts

Recent updates

Abbott Laboratories: When Double-Digit Device Growth Apparently Isn't Enough

Jul 13

These 4 Measures Indicate That Abbott Laboratories (NYSE:ABT) Is Using Debt Reasonably Well

Jul 01
These 4 Measures Indicate That Abbott Laboratories (NYSE:ABT) Is Using Debt Reasonably Well

Abbott Laboratories (NYSE:ABT) Is Doing The Right Things To Multiply Its Share Price

Jun 18
Abbott Laboratories (NYSE:ABT) Is Doing The Right Things To Multiply Its Share Price

Investors Still Waiting For A Pull Back In Abbott Laboratories (NYSE:ABT)

Jun 04
Investors Still Waiting For A Pull Back In Abbott Laboratories (NYSE:ABT)

Abbott Laboratories: Why I Agree With Wall Street On This One

Jun 04

Abbott Laboratories: Buying More Of This Top-Notch Dividend Growth Stock

May 18

Abbott Laboratories: Organic Growth Will Be Key To Q1 Earnings

Apr 17

Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)

Apr 15
Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)

Abbott Laboratories: Buy This World-Class Dividend Growth Stock Now

Mar 21

Abbott Laboratories (NYSE:ABT) Might Have The Makings Of A Multi-Bagger

Mar 19
Abbott Laboratories (NYSE:ABT) Might Have The Makings Of A Multi-Bagger

Here's Why Abbott Laboratories (NYSE:ABT) Can Manage Its Debt Responsibly

Mar 06
Here's Why Abbott Laboratories (NYSE:ABT) Can Manage Its Debt Responsibly

Abbott Labs' Reversal Is Here - CGM Tailwinds In 2024

Feb 27

Abbott Laboratories' (NYSE:ABT) Shares May Have Run Too Fast Too Soon

Feb 08
Abbott Laboratories' (NYSE:ABT) Shares May Have Run Too Fast Too Soon

The King Is Back: Abbott Laboratories' Path To >11% Annual Returns

Jan 29

The Abbott Laboratories (NYSE:ABT) Full-Year Results Are Out And Analysts Have Published New Forecasts

Jan 26
The Abbott Laboratories (NYSE:ABT) Full-Year Results Are Out And Analysts Have Published New Forecasts

Abbott Laboratories: Another Healthy Dividend Hike From This Dividend King

Dec 28

Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)

Dec 27
Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)

Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio

Dec 03

Is Abbott Laboratories (NYSE:ABT) Using Too Much Debt?

Nov 29
Is Abbott Laboratories (NYSE:ABT) Using Too Much Debt?

Abbott Laboratories: One Of The Safest Dividend Growth Stocks On The Market

Nov 26

Abbott Labs Vs. Thermo Fisher: Which Is The Better Healthcare Stock?

Nov 01

Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up

Oct 24
Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up

Abbott: A Diversified Health Care Company With Strong Underlying Growth

Oct 20

Earnings and Revenue Growth Forecasts

NYSE:ABT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202648,1097,8308,980N/A20
12/31/202544,7946,8638,540N/A23
12/31/202441,7515,80110,167N/A22
6/30/202440,7255,535N/AN/AN/A
3/31/202440,3265,6084,9237,143N/A
12/31/202340,1095,7015,0597,261N/A
9/30/202339,9595,1484,4926,549N/A
6/30/202340,2265,1465,4887,452N/A
3/31/202341,5055,7856,8238,659N/A
12/31/202243,6536,9057,8049,581N/A
9/30/202245,0307,8578,54110,322N/A
6/30/202245,5488,5208,46810,243N/A
3/31/202244,5147,6958,1529,961N/A
12/31/202143,0757,0428,64810,533N/A
9/30/202142,3087,2089,31411,264N/A
6/30/202140,2336,3438,64410,629N/A
3/31/202137,3385,6937,6099,823N/A
12/31/202034,6084,4495,7247,901N/A
9/30/202032,2213,3464,5876,519N/A
6/30/202031,4443,0734,5646,401N/A
3/31/202032,0953,5394,4766,139N/A
12/31/201931,9043,6664,4986,136N/A
9/30/201931,3553,2723,8145,485N/A
6/30/201930,9352,8674,0965,720N/A
3/31/201930,7232,5824,4505,904N/A
12/31/201830,5782,3194,9066,300N/A
9/30/201830,4028024,9036,175N/A
6/30/201829,5758124,8165,997N/A
3/31/201828,445365N/A6,104N/A
12/31/201727,390344N/A5,570N/A
9/30/201725,1341,971N/A5,100N/A
6/30/201723,6071,055N/A4,312N/A
3/31/201722,3031,384N/A3,870N/A
12/31/201620,8531,056N/A3,203N/A
9/30/201620,708989N/A2,861N/A
6/30/201620,5561,939N/A2,839N/A
3/31/201620,3932,124N/A2,871N/A
12/31/201520,4052,586N/A2,966N/A
9/30/201520,5732,523N/A3,376N/A
6/30/201520,5022,365N/A3,382N/A
3/31/201520,3892,004N/A3,341N/A
12/31/201420,2471,710N/A3,675N/A
9/30/201419,9051,560N/A4,062N/A
6/30/201419,6511,762N/A3,383N/A
3/31/201419,0341,654N/A3,200N/A
12/31/201319,6571,970N/A3,324N/A
9/30/201320,275961N/A3,202N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ABT's forecast earnings growth (11.8% per year) is above the savings rate (2.4%).

Earnings vs Market: ABT's earnings (11.8% per year) are forecast to grow slower than the US market (14.8% per year).

High Growth Earnings: ABT's earnings are forecast to grow, but not significantly.

Revenue vs Market: ABT's revenue (6.5% per year) is forecast to grow slower than the US market (8.6% per year).

High Growth Revenue: ABT's revenue (6.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ABT's Return on Equity is forecast to be high in 3 years time (21.5%)


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.